Sabra Health Care Reit, INC Form 4 insider transactions

NASDAQ
Director Michael Foster reports changes in beneficial ownership of Sabra Health Care REIT stock due to dividend equivalent payments and holdings in a 401(k) plan.
NASDAQ
Richard K. Matros, Chair, CEO, and President of Sabra Health Care REIT, Inc., reports acquisition of stock units and adjustments to beneficial ownership.
NASDAQ
Director Craig A. Barbarosh reports acquisition of Sabra Health Care REIT shares through dividend equivalent payments and adjustments to holdings in a family trust.
NASDAQ
Jessica Flores, Executive VP & CAO of Sabra Health Care REIT, acquired 348 shares of common stock due to dividend equivalent payments, increasing her total holdings to 59,977 shares.
NASDAQ
Talya Nevo-Hacohen, Executive VP, CIO & Treasurer of Sabra Health Care REIT, Inc., reports acquisition of stock units and adjustments to beneficial ownership, including shares held directly and indirectly through a trust.
NASDAQ
Director Clifton J. Porter II reports the grant of restricted stock units and details of beneficially owned shares in Sabra Health Care REIT.
NASDAQ
Jeffrey A. Malehorn, a director of Sabra Health Care REIT, Inc., reports acquisition and disposal of common stock and grants of restricted stock units.
NASDAQ
Director Ann Kono of Sabra Health Care REIT, Inc. reports the acquisition of restricted stock units and deferred stock units.
NASDAQ
Director Lynne S. Katzmann reported the acquisition of 9,480 restricted stock units and adjustments to her holdings of Sabra Health Care REIT, Inc. common stock.
NASDAQ
Director Michael J. Foster received 9,480 restricted stock units and holds 74,414 shares of Sabra Health Care REIT, Inc.
NASDAQ
Catherine Cusack, a director at Sabra Health Care REIT, Inc., was granted 9,480 shares of common stock on June 13, 2024, under the company's 2009 Performance Incentive Plan.
NASDAQ
Director Craig Barbarosh reports the acquisition of restricted stock units and a disposition of common stock, along with a new power of attorney filing.
NASDAQ
Director Clifton J. Porter II reports acquisition and disposal of Sabra Health Care REIT stock units due to dividend equivalent payments.
NASDAQ
Director Jeffrey A. Malehorn acquired 1,011 shares of Sabra Health Care REIT, Inc. common stock due to dividend equivalent payments on previously granted stock units.
NASDAQ
Ann Kono, a director of Sabra Health Care REIT, reported the acquisition of 719 common stock units due to dividend equivalent payments, increasing her total holdings to 35,663 units.
NASDAQ
Lynne S. Katzmann, a director of Sabra Health Care REIT, acquired 1,076 stock units through dividend equivalent payments on May 31, 2024.
NASDAQ
Director Michael Foster reports acquisition of 1,011 common stock units and disposals of 42,411.745 common stock units through a 401(k) plan.
NASDAQ
Director Catherine Cusack reported the acquisition of 708 common stock units due to dividend equivalent payments and an updated beneficial ownership of 47,093 shares in Sabra Health Care REIT, Inc.
NASDAQ
Director Craig A. Barbarosh reported the acquisition of 1,011 shares of Sabra Health Care REIT, Inc. common stock due to dividend equivalent payments and the disposal of 71,847 shares held indirectly through The Barbarosh Family Trust.
NASDAQ
Executive VP & CAO of Sabra Health Care REIT, Jessica Flores, reports the acquisition of 397 stock units due to dividend equivalent payments.
NASDAQ
Talya Nevo-Hacohen, Executive VP, CIO & Treasurer of Sabra Health Care REIT, reports acquisition of 4,562 shares of common stock due to dividend equivalent payments and adjustments to holdings in a trust.
NASDAQ
Michael Lourenco Costa, Executive VP, CFO & Secretary of Sabra Health Care REIT, Inc., reports changes in beneficial ownership of company stock, including the acquisition of 3,004 shares due to dividend equivalent payments.
NASDAQ
Richard K. Matros, Chair, CEO, and President of Sabra Health Care REIT, reports acquisition of stock units due to dividend equivalent payments and adjustments to holdings in a revocable trust.
NASDAQ
Catherine Cusack, a director of Sabra Health Care REIT, Inc., purchased 7,000 shares of common stock at a price of $14.43 per share on May 22, 2024.
NASDAQ
Director Michael J. Foster sold 10,000 shares of Sabra Health Care REIT, Inc. common stock at a price of $14.683 per share on May 14, 2024.
NASDAQ
Director Clifton J. Porter II acquired 754 shares of Sabra Health Care REIT through dividend equivalent payments and disposed of the same amount, leaving a total of 36,102 shares beneficially owned.
NASDAQ
Jeffrey A. Malehorn, a director of Sabra Health Care REIT, acquired 1,040 common stock units through dividend equivalent payments on February 29, 2024, increasing his total holdings to 82,573 shares.
NASDAQ
Director Ann Kono reports acquisition of 741 stock units in Sabra Health Care REIT due to dividend equivalent payments, increasing her holdings to 34,944 units.
NASDAQ
Director Lynne S. Katzmann reports acquisition of 1,108 common stock units due to dividend equivalent payments and adjustments to holdings of unvested and deferred stock units.
NASDAQ
Director Michael J. Foster reports acquisition of 1,040 shares of Sabra Health Care REIT, Inc. common stock through dividend equivalent payments.